Ekso Bionics Holdings Inc [EKSO] stock prices are up 3.63% to $8.86 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The EKSO shares have gain 11.73% over the last week, with a monthly amount glided 88.51%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Ekso Bionics Holdings Inc [EKSO] has been fluctuating between $2.73 and $12.70 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Ekso Bionics Holdings Inc [NASDAQ: EKSO] shares were valued at $8.86 at the most recent close of the market. An investor can expect a potential drop of -32.28% based on the average EKSO price forecast.
Analyzing the EKSO fundamentals
The Ekso Bionics Holdings Inc [NASDAQ:EKSO] reported sales of 14.75M for trailing twelve months, representing a surge of 2.37%. Gross Profit Margin for this corporation currently stands at 0.53% with Operating Profit Margin at -0.75%, Pretax Profit Margin comes in at -0.71%, and Net Profit Margin reading is -0.71%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -0.91 and Total Capital is -0.87. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Ekso Bionics Holdings Inc [NASDAQ:EKSO]’s Current Ratio is 1.66. Also, the Quick Ratio is 1.09, while the Cash Ratio stands at 0.3. Considering the valuation of this stock, the price to sales ratio is 2.04, the price to book ratio is 2.40.
Transactions by insiders
Recent insider trading involved Jones Jason C, Chief Operating Officer, that happened on Jan 06 ’26 when 1320.0 shares were sold. Chief Operating Officer, Jones Jason C completed a deal on Dec 09 ’25 to sell 270.0 shares. Meanwhile, Chief Financial Officer Wong Jerome sold 1238.0 shares on Dec 09 ’25.
